London, UK – 10 June 2013 – Connect Digital Health, organisers of the forthcoming Digital Health Forum 2013 (DHF13) to be held in London on 11 June, has announced the top speaker line-up for the event, including leading journalists, authors, business strategists and successful entrepreneurs.
The conference will feature founders, investors, partners, venture capitalists and technologists from the digital health world. Speakers announced today include:
• Prolific start-up investor and former Wall Street technology analyst Esther Dyson, who has funded or advised more than twenty life science and digital health companies, including 23andMe, Sleepio and Genomera.
• Best-selling author David Ewing Duncan who writes for The New York Times, Fortune, Wired, National Geographic, Discover, Atlantic Monthly, and many other publications. He is a Correspondent for The Atlantic, and the Chief Correspondent of public radio's Biotech Nation, heard on NPR Talk.
• Futurist Tamar Kasriel, who founded London-based consultancy Futureal, helping businesses to adjust their commercial strategy to be robust during change. Tamar is listed by Wired as amongst the world’s most influential futurists.
• Medtronic Senior VP Medicine & Technology Stephen Oesterle, who develops the company’s technical strategies and provides leadership for its scientific research. He developed interventional cardiology programmes at several notable US hospitals and pioneered cardiac catheterisation techniques that are now commonplace around the world.
Esther Dyson, Founder of Health Intervention Coordinating Council (HICCup) said:
“I'm really looking forward to DHF. It's a great place for finding out what's going on - and what should be going on - in digital health!”
David Ewing Duncan, Chief Correspondent of public radio's Biotech Nation commented:
"As we generate tsunamis of data about health and biomedicine, meetings like DHF are desperately needed to gather top innovators from around the world to creatively channel the flow."
To be held at the Royal Society of Medicine, London, UK, DHF13 will host key executives from across the digital health ecosystem, showcase the best ‘deal-ready’ digital health companies from around the world and facilitate meetings with potential investors and corporate partners from the pharmaceutical, biotechnology, medical device, big data, IT, software and hardware industries. Full programme information is available online at www.dhf13.com.
Notes to Editors
About Connect Digital Health
Connect Digital Health (CDH) encourages entrepreneurship, promotes investment and nurtures industry collaborations focused on the development of digital tools that improve healthcare outcomes. CDH believes that the future of the digital health industry is predicated on improvement of healthcare outcomes. CDH’s goals are to help entrepreneurs realise potential, assist investors via a collaborative platform to develop opportunities and help large companies access innovation in addition to helping manage change in an industry experiencing this at an unprecedented speed. For more information please visit www.connectdigitalhealth.com.
Digital Health Forum for Investors & Industry 2013 (DHF13) showcases the best ‘deal-ready’ digital health companies from around the world and enables them to meet with potential investor and corporate partners from the pharmaceutical, biotechnology, medical device, big data, IT, software and hardware industries. This conference addresses the need to build new relationships and connections which are better suited to the rapidly changing healthcare landscape. For more information please visit www.dhf13.com.
Issued for and on behalf of Connect Digital Health.
To contact the Connect Digital Health team at College Hil, email CDH@collegehill.com